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It is not unusual for patients with “rare” conditions, such as skeletal dysplasias, to remain undiagnosed until
adulthood. In such cases, a pregnancy may unexpectedly reveal hidden problems and special needs. A 28 year old
primigravida was referred to us at 17 weeks for counselling with an undiagnosed skeletal dysplasia with specific
skeletal anomalies suggesting the collagen 2 disorder, spondyloperipheral dysplasia (SPD; MIM 156550).
She was counselled about the probability of dominant inheritance and was offered a prenatal diagnosis by
sonography. US examination at 17, 18 and 20 weeks revealed fetal macrocephaly, a narrow thorax, and shortening
and bowing of long bones. The parents elected to continue the pregnancy. At birth the baby showed severe
respiratory distress for four weeks which then resolved. Mutation analysis of both mother and child revealed a
hitherto undescribed heterozygous nonsense mutation in the C-propeptide coding region of COL2A1 confirming
the diagnosis of SPD while reinforcing the genotype-phenotype correlations between C-propeptide COL2A1
mutations and the SPD-Torrance spectrum. This case demonstrates the importance of a correct diagnosis even in
adulthood, enabling individuals affected by rare conditions to be made aware about recurrence and pregnancy-
associated risks, and potential complications in the newborn.
Background
Type II collagenopathies range from lethal forms
(Achondrogenesis II, Hypochondrogenesis), to severe
diseases (spondyloepiphyseal dysplasia congenital, Kniest
dysplasia) to mild phenotypes (Stickler dysplasia, a mild
dominant spondyloarthropathy) [1]. Heterozygous muta-
tions mapping to different parts of the triple helical
domain of the COL2A1 gene have been identified for
most of these disorders. Spondyloperipheral dysplasia
(SPD-OMIM 156550) is a skeletal dysplasia with platy-
spondyly and brachydactyly E changes, first described in
1977 [2]. Additional cases were later reported with some
similarities but with considerable clinical variability [3-5]
but all of them exhibited autosomal dominant
inheritance with duplications, truncating mutations and
missense mutations of C-propeptide of the COL2A1
gene having been previously reported [4-6]. Here we
describe a family, a mother and her son, with SPD and
a novel truncating mutation in the C-propeptide domain
of COL2A1.
Case presentation: Patient 1
Patient 1, the mother, is the first girl of healthy, non-
consanguineous Caucasian parents who was sponta-
neously delivered at term after an uneventful pregnancy.
Family history was unremarkable for mental retardation
or birth defects.
Her growth parameters were always below the 3rd
centile and she reached her final height of 115 cm at
16 years old. At 2 months she underwent surgical cor-
rection of club feet.
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Clausen (DMC) syndrome was made in another Centre
and the parents were advised accordingly. She was diag-
nosed with bilateral otosclerosis at 16 years and under-
went a tympanum replacement in the left ear. She has
had mild conductive hypoacusia since then. She devel-
oped moderate scoliosis and suffered intermittent back
pain and hip and knee stiffness. Despite these medical
problems, she was healthy and she had an active life.
At time of her first pregnancy she was referred to our
Centre at 17 weeks of gestation following a sonogram
which had revealed a fetal femur length below the 3rd
centile.
At the time of referral her auxological parameters
measured: weight 55 kg (25-50th centile), height 115 cm
(-4DS), OFC 57 cm (97th centile). Arm length was
121 cm, lower segment length was 60 cm and upper
segment length 55 cm. Hand length was 15 cm (<3rd
centile) and middle finger 5,5 cm (<3rd centile). She was
macrocephalic, with a round face and mild midface
hypoplasia. Present were kyphosis, mild lumbar lordosis
and bilateral E brachydactyly of the hands and shortened
toes 2 to 5. A prominent first toe (Brachydactyly E) was
also noted (Figure 1, 2).
A re-evaluation of the radiographic images taken at
ages 4 and 28 years, demonstrated platyspondyly,
reduced intervertebral space, bell shaped thorax, scolio-
sis, broad ilia with hypoplasia of the basilar portions,
shortening of the long bones with flared ends (metha-
physeal enlargement), short femoral ends, mild genu
valgum, bilateral brachymetaphalangia of the fifth finger
of the hand (Brachydactyly E-like) and brachymetatarsia
of the four toes similar to brachydactyly E (Figure 3, 4).
Except for the presence of the brachydactyly, many of
the patient’s clinical and radiographic features were
compatible with a type II collagen disorder, in particular
with spondyloepiphyseal dysplasia congenita or Kniest
dysplasia. Specifically, our patient demonstrated a num-
ber of similarities with the cases described by Zankl
et al 2004 [4] which had been used to define SPD.
The woman was informed about the high risk of
transmission and an ultrasound prenatal diagnosis was
offered. Ultrasound examinations between 18 and
32 week of gestation revealed fetal macrocephaly, nar-
rowed thorax, severe shortening and bowing of long
bones (<<3° centile), a cardiac-thoracic ratio of 0,48
with a cardiothoracic/cardio abdominal ratio of 80%,
lateral cerebral ventricles measuring 7 mm, regular
Figure 1 Radiographs of hands. Note mild shortening of the fifth metacarpal of the hands.
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Page 2 of 8Figure 2 Radiographs of feet. Note the 2
nd and 4
th metatarsal bones and the great toe.
Figure 3 Radiographs of patient 1. A. 4 years. B. 28 years. Note short iliac bones, flattened femoral heads, short and broad femoral neck. Short
femoral and tibial diaphysys, methaphyseal widening and broad femoral ends.
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volume (Figure 5). Following extensive counseling the
parents decided to continue the pregnancy.
During the pregnancy, the woman was offered a com-
plete workup including a cardiac, pneumological, ortho-
paedic and obstetric examinations every month from the
17th to the 32nd week. All parameters remained within
the normal range.
She reported a reasonably good quality of life during
the second trimester but in the 32nd week she was
admitted to the hospital to induce foetal lung matura-
tion by corticosteroids.
The baby, a male, was born through a transverse cae-
sarean section performed at the 33rd week under spinal
anesthesia.
Case presentation: Patient 2
Patient 2, the child had the following measurements at
birth: weight 1780 gr (10-25th centile), length 32 cm (-4
DS) and OFD 32 cm (75th centile). Apgar scores were 3, 7
and 8 at one, five and ten minutes respectively. Because of
difficulties with respiration a naso-tracheal tube was
inserted and breathing was aided by mechanical ventila-
tion. The child was initially treated with a high-frequency
ventilation for one day and with conventional mechanical
ventilation for 12 days. For the following 25 days the child
was maintained in nasal Continuous Positive Airway Pres-
sure (CPAP). Oxygen therapy was discontinued at 41
weeks of age. A single dose of exogenous surfactant was
administered. Afterwards occasional desaturation episodes
were noted with spontaneous resolution. Enteric feeding
was initiated on the second day of life and was maintained
until week 38 when the baby was started on bottle feeding.
Clinical evaluation showed a flat face, apparent hyper-
telorism, depressed nasal bridge, small upturned nose,
midface hypoplasia, micrognathia, ulnar deviation of
hands and club feet (Figure 6).
Cardiac examination was normal. Retinal immaturity was
observed. Radiographic examination performed at 2 months
of age revealed a large skull, mild platyspondyly with ovoid-
pear-shaped vertebral bodies, delayed ossification of pubic
bones, distal femoral and proximal tibial epiphyses, shor-
tened and broad tubular bones with splayed and cupped
metaphyses, mild bowing of the tibiae (Figure 7).
Molecular studies
After informed consent was obtained from both indivi-
duals, blood was drawn and genomic DNA of both
Figure 4 Radiographs of patient 1. A. 6 years. B. 28 years. Note generalized platyspondyly, thoracolumbar scoliosis.
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leukocytes using standard protocols.
Coding regions, intron-exon boundaries and flanking
intronic sequences of the COL2A1 gene were amplified
by PCR. Amplified PCR products were monitored on
1.5% agarose gels.
PCR products were subjected to a denaturing step of
2 minutes at 96°C followed by gradual annealing. The
annealing time of each cycle was 30 seconds followed
by 50 cycles of cooling from 96°C to 46°C with a
decremented gradient temperature of 1°C then 7 min-
utes at room temperature, to promote heteroduplex
formation.
dHPLC analysis was performed using the Wave
MD4000 Transgenomic
® device and analysis of the
results was carried out by Navigator
® version 1.6.4
software.
Fragments which indicated differences from a known
negative control, were sequenced bidirectionally on an
ABI 3100 Genetic Analyzer (Applied Biosystems).
Each mutation was confirmed by re-amplification of a
second DNA product and re-sequencing.
In patients 1 and 2 we identified a heterozygous non-
sense mutation (c.4339 A > T) in exon 54, which
resulted in a premature stop codon at amino acid 1447
(K1447X). (Exon and nucleotide numbering based on
Figure 5 Fetal auxological measurements showing the shortening of the femur beginning with the 15th the week of gestation.
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Page 5 of 8Figure 6 Patient 2, 2 years. Note flat mid-face, depressed nasal bridge.
Figure 7 Radiological features of patient 2. There is retarded ossification of the skeleton with absence of the ossification centres of pubic
bones and distal femoral and proximal tibial epiphyses. Mild platyspondyly with ovoid-pear-shaped vertebral bodies. The tubular bones are short
and broad with splayed ends and cupped metaphyses and mild bowing of the tibiae.
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initiation codon).
Discussion
This study describes a mother and her son, affected by
severe dwarfism, peculiar facial features, similar radiolo-
gical findings including shortened tubular bones, specific
vertebral alterations being pear-shaped in infancy and
platyspondylic by adulthood; metaphyseal and epiphyseal
alterations and brachydactyly E. Even though our patient
presented with the typical radiological features of type 2
collagenopathy, she was not correctly diagnosed until
age 28 years.
This misidentification induced a series of conse-
quences ranging from an incorrect knowledge of repro-
ductive risk, a poor understanding of the clinical
variability of her condition and a failure to correctly
identify fetal and neonatal risks. After being correctly
diagnosed at the 17th week of gestation this young
woman was faced with the decision either to terminate
or to carry on the pregnancy and face the birth of an
affected child. We believe the final decision to continue
the pregnancy was supported by her good self image
despite the physical diversity.
Because she decided to not to terminate it was neces-
sary to assemble a multidisciplinary team including
obstetricians, orthopaedists, cardiologists, a pneumolo-
gist and an anaesthetist to monitor cardio-respiratory
and orthopaedic complications. Fortunately, the mother
demonstrated a good cardio-respiratory response despite
her severe dwarfism and skeletal abnormalities.
Mutation analysis of our cases revealed a hitherto
undescribed, heterozygous nonsense mutation in the C-
propeptide coding region of COL2A1 (c.4339 A > T,
K1447X) in exon 54. Mutations of the C-propeptide of
collagen II are a well established cause of type II col-
lagenopathy associated with brachydactyly E; indeed,
additional cases of SPD associated to analogous muta-
tions of C propeptide domain of COL2A1 have been
previously reported [4,5].
Brachydactyly E associated with metaphyseal changes is
the most peculiar clinical feature of C propeptide muta-
tions of collagen type 2, which differentiate them from
other types of collagenopathies. It must be remembered
that brachydactyly E is not only associated with SPD, but
is part of clinical picture of other type 2 collagenopathies
such as Czech dysplasia and platyspondylic lethal skeletal
dysplasia, Torrance type (PLSD-T).
Czech dysplasia is characterized by early-onset, pro-
gressive pseudo-rheumatoid arthritis, hearing loss start-
ing in early adulthood, vertebral anomalies (mild
platyspondyly, irregular plates reduced intervertebral
distances), normal stature and short third and fourth
toes. A specific typical missense mutation (R275C) in
the triple helical domain of the COL2A1 gene has been
identified [6]. In contrast to Czech dysplasia, spondylo-
peripheral dysplasia (SPD) is characterized by short sta-
ture, clubfeet, platyspondyly, midface hypoplasia, myopia
and epiphyseal dysplasia.
Platyspondylic lethal skeletal dysplasia, Torrance type
(PLSD-T) is a rare form of skeletal dysplasia characterized
by platyspondyly, brachydactyly and methapyseal changes.
Mutations in COL2A1 have been identified in the Tor-
r a n c et y p e[ 7 ] .W h i l em o s tr e p o r t so fP L S D - Td e s c r i b e
sporadic and perinatally lethal cases, patients with longer
survival have been recently reported [8]. Zankl et al.
reported 8 further cases of PLSD- T and found that all
had COL2A1 mutations in the C-propeptide domain. The
mutational spectrum included missense, stop codon and
frameshift mutations. Two of those patients, who showed
the rare adult form of PLSD-T, had given birth to children
with a lethal PLSD-T [9].
Our patient 2 showed radiological features as platy-
spondyly, ovoid vertebrae, delayed ossification of pubic
bones, shortened and broad tubular bones with splayed
a n dr a g g e dm e t a p h y s e ss i m i l a rt oaf o r mo fP L S D - T ,
whereas clinical and radiological features of our patient
1 overlap with SPD. This observation further supports
the conclusion that SPD and PLSD-T are not two etio-
logically distinct entities but belong to the same conti-
nuum phenotypic spectrum.
The aetiology of the two conditions has been recently
established through the findings of mutations in C-
propeptide domain of COL2A1. Of note is the charac-
terisation of the mutation in our case, a novel nonsense
mutation (c.4339 A > T) in exon 54, which resulted in a
premature stop codon at amino acid 1447 (K1447X).
This mutation is located at the farthest 3’end of the
domain analogous to the SPD and PLSD-T mutations so
far detected; the specific site of these mutations seems
to allow abnormal molecules to escape from mRNA
decay. This evidence has led to the hypothesis that the
combination of toxic effects arising from the accumula-
tion of altered collagen chains inside the chondrocytes,
diminished collagen fibril formation, and alteration of a
putative signaling function of the carboxy-propeptide of
type 2 collagen are the root cause of SPD and PLSD-T
pathogenesis [9].
In conclusion this family is an excellent example of the
need for a correct diagnosis in adulthood, the evidence of
wide variability of these type of collagenopathies in terms
of etiology and pathogenesis. Genetic counseling in these
situations is very challenging and should take into
account all the different aspects of rare disease.
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